Free Trial
NASDAQ:NIVF

NewGenIvf Group Q4 2025 Earnings Report

NewGenIvf Group logo
$0.13 +0.03 (+27.72%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.13 0.00 (-1.55%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NewGenIvf Group EPS Results

Actual EPS
-$2,585.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NewGenIvf Group Revenue Results

Actual Revenue
$1.42 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NewGenIvf Group Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NewGenIvf Group Earnings Headlines

NewGenIvf Group Limited Closes $1.25 Million Public Offering
NewGen Announces Closing of $1.25 Million Public Offering
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company the same size Nvidia was a decade ago. Brown says this firm's patented technology can produce intelligence up to 1,000 times faster than standard AI, and he expects Elon Musk to fuel demand starting November 11. The technology is protected by 150 patents.tc pixel
NewGenIvf Group Ltd Class A (NIVF)
NewGen Announces Pricing of $1.25 Million Public Offering
See More NewGenIvf Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NewGenIvf Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NewGenIvf Group and other key companies, straight to your email.

About NewGenIvf Group

NewGenIvf Group (NASDAQ:NIVF) is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing. The company also offers fertility preservation and related programs, subject to applicable medical and regulatory requirements.

NewGenIvf Group is headquartered in Thailand and focuses primarily on patients in Thailand and the broader Southeast Asian market. The company’s operations are centered on fertility clinics and supporting laboratory services. Publicly available information about its corporate history and leadership is limited, so additional details are not included here.

View NewGenIvf Group Profile